Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Improving Accuracy in Lung Cancer Diagnosis through Biomarker Discovery

Yehn Ching

Lung cancer is a leading cause of cancer-related deaths worldwide, necessitating the continuous development of innovative diagnostic approaches to improve early detection and patient outcomes. This comprehensive review explores the latest advancements in lung cancer diagnosis, encompassing a wide range of diagnostic modalities and techniques. We discuss the significance of early detection and its impact on prognosis, emphasizing the role of imaging modalities, biomarker discovery, and liquid biopsies. Furthermore, we delve into the emerging field of precision medicine and its implications for personalized lung cancer diagnosis and treatment. Challenges and future directions in lung cancer diagnosis are also addressed. This review aims to provide a holistic understanding of the current state of lung cancer diagnosis and guide further research efforts in this critical area of oncology.